April 14, 2025
The U.S. Food and Drug Administration (FDA) and Novo Nordisk are warning people not to use counterfeit semaglutide 1.0 mg (Ozempic injection) found in the US […]
April 11, 2025
Malnutrition-related diabetes, distinct from both type 1 and type 2, has now been officially recognized and named “type 5 diabetes.” The vote to endorse the category […]
April 11, 2025
The adjunctive use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) as an addition to insulin is increasingly viewed as a method for addressing the rising […]
April 11, 2025
At least two recent studies have found bariatric surgery more cost-effective, long term, than the pricey glucagon-like peptide 1 (GLP-1) receptor agonist obesity medications. Another recent […]
April 10, 2025
The Dexcom G7 continuous glucose monitor (CGM) will now last 15 days, up from the previous 10-day version. The US Food and Drug Administration’s clearance of […]
April 10, 2025
TOPLINE: Compared with a conventional ad libitum Mediterranean diet, an energy-restricted Mediterranean diet along with physical activity helped preserve bone mineral density (BMD) during weight loss […]
April 9, 2025
The increasing use of technology for treating type 1 diabetes (T1D) has improved glycemic control; however, it hasn’t eliminated the risk for diabetic ketoacidosis (DKA). In […]
April 8, 2025
TOPLINE: Urine normetanephrines were linked to an increased risk for mortality in patients with adrenal adenomas, with a 47% higher risk observed per 100 μmol/mol creatinine […]
April 7, 2025
Around 38 million people in the United States — or slightly over 11% of the population — have diabetes, according to the National Diabetes Statistics Report. […]